Insider Transactions in Q3 2021 at Turning Point Therapeutics, Inc. (TPTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 30
2021
|
Annette North EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
10,000
-44.71%
|
$800,000
$80.0 P/Share
|
|
Aug 30
2021
|
Annette North EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+30.9%
|
$170,000
$17.0 P/Share
|
|
Jul 26
2021
|
Paolo Tombesi EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,600
+50.0%
|
-
|
|
Jul 14
2021
|
Andrew John Partridge EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,869
-7.91%
|
$138,306
$74.9 P/Share
|